Pricing

Cellular Biomedicine Group Inc (CBMG)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Bizuo Liu
Employees:
193
9605 MEDICAL CENTER DRIVE, SUITE 100, ROCKVILLE, MD, 20850
(301) 825 5320

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

    Formally known as:
  • CELLULAR BIOMEDICINE GROUP, INC.
  • EASTBRIDGE INVESTMENT GROUP
  • Eastbridge Investment Group Corp.
  • Eastbridge Investment Group Corp.
Stock Split History
DateRatio
2013-01-31 1:100
Cellular Biomedicine Group, Inc. is a biopharmaceutical company. The company engages in the development of treatments for degenerative and cancerous diseases utilizing proprietary cell-based technologies. Its technology include immune cell therapy for treatment of a range of cancers using Chimeric Antigen Receptor T cell, cancer vaccine, and T Central Memory cell technology; and human adipose-derived mesenchymal progenitor cells for treatment of joint and autoimmune diseases, with primary research and manufacturing facilities in China. Cellular Biomedicine Group was founded in 2009 and is headquartered in Cupertino, CA.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available